[1]
Dolzhenko, M.M. and Bondarchuk, S.A. 2021. Comparative efficacy and predictive value of fixed combination of amlodipine and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in patients with coronary heart disease, post-infarction cardiosclerosis and hypertension. Zaporozhye Medical Journal. 23, 6 (Oct. 2021), 791–799. DOI:https://doi.org/10.14739/2310-1210.2021.6.240999.